HARROW HEALTH, INC. Consulting Agreements
15 Contracts & Agreements
- Consulting Agreement dated July 1, 2020 between Visionology, Inc. and Mark L. Baum (Filed With SEC on March 8, 2021)
- Consulting Agreement dated July 1, 2020 between Visionology, Inc. and Andrew R. Boll (Filed With SEC on March 8, 2021)
- Consulting Agreement dated February 13, 2020 between Stowe Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on March 13, 2020)
- Consulting Agreement dated February 13, 2020 between Stowe Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on March 13, 2020)
- Consulting Agreement dated February 13, 2020 between Stowe Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on March 13, 2020)
- Consulting Agreement dated June 3, 2019 between Mayfield Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on August 14, 2019)
- Consulting Agreement dated June 3, 2019 between Mayfield Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on August 14, 2019)
- Consulting Agreement dated June 3, 2019 between Mayfield Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on August 14, 2019)
- Consulting Agreement dated May 1, 2018 between Melt Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on November 13, 2018)
- Consulting Agreement dated May 1, 2018 between Melt Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on November 13, 2018)
- Consulting Agreement dated May 1, 2018 between Melt Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on November 13, 2018)
- Consulting Agreement dated March 1, 2018 between Surface Pharmaceuticals, Inc. and Richard L. Lindstrom, M.D (Filed With SEC on August 6, 2018)
- Consulting Agreement dated October 27, 2017 between Surface Pharmaceuticals, Inc. and Mark L. Baum (Filed With SEC on March 8, 2018)
- Consulting Agreement dated October 27, 2017 between Surface Pharmaceuticals, Inc. and Andrew R. Boll (Filed With SEC on March 8, 2018)
- Consulting Agreement dated October 27, 2017 between Surface Pharmaceuticals, Inc. and John P. Saharek (Filed With SEC on March 8, 2018)